Advertisement
Document › Details
Consilium Strategic Communications Ltd.. (7/10/19). "Press Release: Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum 2019 at London Stock Exchange". London.
Region | London, Greater London | |
Country | United Kingdom (GB) | |
Organisation | Consilium Strategic Communications Ltd. | |
Today | ICR Consilium (Consilium Strategic Communications Ltd.) | |
Group | ICR (Group) | |
Organisation 2 | London Stock Exchange plc (LSE) | |
Product | Future of Healthcare Investor Forum 2019 London | |
Product 2 | healthcare | |
Person | Gardner, Chris (Consilium 201507– Partner before since 2003 at Citigate Dewe Rogerson London) | |
Person 2 | Hancock, Matt (United Kingdom (govt) 201907 Secretary of State for Health and Social Care) | |
Consilium Strategic Communications (“Consilium”), a global leader in strategic healthcare communications and investor relations, today joins co-sponsors J.P. Morgan and Numis, partner The BioIndustry Association (BIA), and co-hosts London Stock Exchange and MedCity at the fifth annual Future of Healthcare Investor Forum.
The forum will hear about the opportunities of investing in the healthcare sector from leading public and private companies, members of the investment community and expert advisors, who all understand what it takes to fund and grow innovative healthcare companies.
Also joining the half-day, invitation-only event is the Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care who will be providing a keynote speech on healthcare, the economy and long-term patient capital.
“This has been a positive year for innovation in healthcare and the Future of Healthcare Investor Forum is a great opportunity to take stock of developments over the first half and gain real insight into the sector and current investment trends. We look forward to a morning of high-quality discussion at what is one of London’s leading healthcare investment meetings," said Chris Gardner, PhD, Partner at Consilium Strategic Communications.
For more information on the Future of Healthcare Investor Forum, please see: https://www.lseg.com/HealthcareInvestorForum2019
For more information please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell / Chris Gardner
Tel: +44(0)20 3709 5700
[email protected]
www.consilium-comms.com
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in financial and corporate communications and investor relations focused on the healthcare sector. Consilium's team, based in both Europe and US, provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes, international media management, transactions and healthcare stakeholder challenges. Consilium has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects. For more information please see www.consilium-comms.com
Record changed: 2024-12-22 |
Advertisement
More documents for ICR (Group)
- [1] Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss....
- [2] ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London....
- [3] ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY....
- [4] Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London....
- [5] Alentis Therapeutics AG. (1/9/23). "Press Release: Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1". Basel....
- [6] Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London....
- [7] OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford....
- [8] Emergex Vaccines Holding Ltd.. (11/18/20). "Press Release: Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases". Abingdon....
- [9] Consilium Strategic Communications Ltd.. (11/10/20). "Press Release: Consilium Strategic Communications Strengthens Global Team in the US and Europe". London....
- [10] Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top